Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

BGM0504

A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects.

BrightGene Bio-Medical Technology Co · Phase 2 · Completed · Enrollment 60

NCT07836140

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Semaglutiden/rn/rn/rn/r
BGM0504n/rn/rn/rn/r

Not shown

  • Semaglutide: endpoint not reported
  • BGM0504: endpoint not reported